Abstract
The biological revolution underscores the success of the federal government’s commitment to the support of basic research: the billions for health research through the National Institute of Health (NIH) in the 1950s and 1960s directly led to the discovery of recombinant DNA technology. As Dr. Donald Fredrickson, the former NIH director, has noted, there is a flood of basic discoveries in biochemistry, physiology, and medicine fueling today’s revolution in biology. In a recent address, Dr. James Wyngaarden, the current NIH director, observed that the traditional biomedical research disciplines are becoming increasingly unified scientifically, in Dr. Arthur Kornberg’s words, “by the common language of chemistry.” For purposes of definition for this chapter, the focus is on biotechnology, a broad term that weds the fermentation industry and the new fermentation technologies with the genetic engineering industry, principally recombinant DNA technology and cell fusion, better known as hybridomas and monoclonal antibodies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References and Notes
See generally Perpich, J. G., Guest Editor, Biotechnology-The Impact on Societal Institutions, in Technology in Society 4(4) (1982), 5(1)
. See generally Perpich, J. G., Guest Editor, Biotechnology-The Impact on Societal Institutions, in Technology in Society 5(3) (1983).
. See generally Perpich, J. G., Guest Editor, Biotechnology-The Impact on Societal Institutions, in Technology in Society 6(1) (1984).
Krause, R., Is the biological revolution a match for the trinity of despair, Technology in Society 4(4): 267– 282 (1982).
Commercial biotechnology: An international analysis, U.S. Congress, Office of Technology Assessment, Washington, DC (Jan. 1984).
See generally Perpich, J. G., Genetic engineering and related biotechnologies: Scientific progress and public policy, Technology in Society 5(1):27–49 (1983).
Perpich, J. G., Industrial involvement in the development of NIH recombinant DNA research guidelines and related federal policies, Recombinant DNA Technical Bulletin 5:59–79 (June 1982).
Capron, A. M., Human genetic engineering, Technology in Society 6(l):23–37 (1984).
Alexander, M, Spread of organisms with novel genotypes, AAAS Advisory Committee, seminar series on bioengineering (sponsored by the Environmental Protection Agency), May 17, 1983, Washington, D.C. (in press).
Donalds, J. E., Applications of Biotechnology in the Chemical Industry, AAAS Advisory Committee, seminar series on bioengineering (sponsored by the Environmental Protection Agency), February 9, 1983, Washington, D.C. (in press).
Schmitt, H., Biotechnology and the lawmakers, Technology in Society 5(1):5–14 (1983).
Thomas, L. S., Oswald Avery and the cascade of surprises, Technology in Society 6(1):37–41 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Aubrey Milunsky and George J. Annas
About this chapter
Cite this chapter
Perpich, J.G. (1985). The Biotechnology Industry. In: Milunsky, A., Annas, G.J. (eds) Genetics and the Law III. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4952-5_30
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4952-5_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4954-9
Online ISBN: 978-1-4684-4952-5
eBook Packages: Springer Book Archive